Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model

Innate Immunity

Volumn 20, Issue 1, 2014, Pages 30-39

  Wirthgen, Elisa ^a   Tuchscherer, Margret ^a   Otten, Winfried ^a   Domanska, Grazyna ^b   Wollenhaupt, Karin ^a   Tuchscherer, Armin ^a   Kanitz, Ellen ^a  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

3 dioxygenase; Indoleamine 2; kynurenine pathway; LPS; pig

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; KYNURENINE; LIPOPOLYSACCHARIDE; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; BRAIN TISSUE; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; IN VIVO STUDY; LIVER; LUNG; MALE; MUSCLE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REACTION TIME; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TRYPTOPHAN METABOLISM;

3-DIOXYGENASE; INDOLEAMINE 2; KYNURENINE PATHWAY; LPS; PIG;

ANIMALS; BLOOD CELLS; CELLS, CULTURED; ENZYME ACTIVATION; FEASIBILITY STUDIES; HUMANS; IMMUNE SYSTEM DISEASES; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; KYNURENINE; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; MODELS, ANIMAL; SWINE; TRYPTOPHAN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84891288694     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913481252     Document Type: Article

References (42)

1. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immuno. 2004 ; 4: 762-774
2. King NJC, Thomas SR. Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol. 2007 ; 39: 2167-2172
3. Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H, Seishima M. The signal transducer and activator of transcription 1alpha and interferon regulator factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem. 2006 ; 139: 655-662
4. Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism. Biochem Biophys Res Commun. 2005 ; 338: 12-19
5. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998 ; 281: 1191-1193
6. O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatr. 2008 ; 14: 511-522
7. Fu X, Zunich SM, O'Connor JC, Kavelaars A, Dantzer R, Kelley KW. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3-dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflamm. 2010 ; 7: 43-43
8. Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Med. 2003 ; 9: 1269-1274
9. Huttunen R, Syrjänen J, Aittoniemi J, Oja S, Raitala A, Laine J, et al. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock. 2010 ; 33: 149-154
10. Guillemin GJ, Meininger V, Brew BJ. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegener Dis. 2005 ; 2: 166-176
11. Erhardt S, Schwieler L, Nilsson L, Linderholm K, Engberg G. The kynurenic acid hypothesis of schizophrenia. Physiol Behav. 2007 ; 92: 203-209
12. Heyes MP, Swartz KJ, Markey SP, Beal MF. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neuroscilett. 1991 ; 122: 265-269
13. Bendixen E, Danielsen M, Larsen K, Bendixen C. Advances in porcine genomics and proteomics-a toolbox for developing the pig as a model organism for molrcular biomedical research. Brief Funct Genomics. 2010 ; 9: 208-219
14. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol. 2012 ; 20: 50-57
15. Thorgersen EB, Hellerud BC, Nielson EW, Barratt-Due A, Fure H, et al. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J. 2010 ; 24: 712-722
16. Tuchscherer M, Kanitz E, Puppe B, Tuchscherer A, Stabenow B. Effects of postnatal social isolation on hormonal and immune responses of pigs to an acute endotoxin challenge. Physiol Behav. 2004 ; 82: 503-511
17. Tuchscherer M, Kanitz E, Puppe B, Tuchscherer A, Viergutz T. Changes in endocrine and immune responses of neonatal pigs exposed to a psychosocial stressor. Res Vet Sci. 2009 ; 87: 380-388
18. Felix B, Leger ME, Albe-Fessard D Stereotaxic atlas of the pig brain. Amsterdam: Elsevier ; 1999 :
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
20. Kiank C, Zeden JP, Drude S, Domanska G, Fusch G, Otten W, Schuett C. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PloS One. 2010 ; 5: e11825 - e11825
21. Weichselbaum TE. An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Amer J Clin Pathol. 1946 ; 10: 40-49
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685
23. Webel DM, Finck BN, Baker DH, Johnson RW. Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide. J Anim Sci. 1997 ; 75: 1514-1520
24. Li J, Li DF, Xing JJ, Cheng ZB, Lai CH. Effects of β-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide. J Anim Sci. 2006 ; 84: 2374-2381
25. Lipcsey M, Larsson A, Eriksson MB, Sjölin J. Effect of the administration rate on the biological responses to a fixed dose of endotoxin in the anesthetized pig. Shock. 2008 ; 29: 173-180
26. González A, Varo N, Alegre E, Díaz A, Melero I. Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. Adv Clin Chem. 2008 ; 45: 155-197
27. Fujigaki S, Saito K, Sekikawa K, Tone S, Takikawa O, Fujii H, et al. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur J Immunol. 2001 ; 31: 2313-2318
28. De Waal MR, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 ; 174: 1209-1220
29. Jung ID, Lee MG, Chang JH, Lee JS, Jeong YI, Lee CM, et al. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J Immunol. 2009 ; 182: 3146-3154
30. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev. 2003 ; 55: 241-269
31. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol. 1993 ; 47: 169-176
32. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003 ; 9: 125-134
33. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009 ; 265: 663-679
34. Melchior D, Le Floc'h N, Sève B. Effects of chronic lung inflammation on tryptophan metabolism in piglets. Adv Exp Med Biol. 2003 ; 527: 359-362
35. Melchior D, Mézière N, Sève B, Le Floc'h N. Is tryptophan catabolism increased under indoleamine 2,3dioxygenase activity during chronic lung inflammation in pigs?. Reprod Nutr Develop. 2005 ; 45: 175-183
36. Le Floc'h N, Melchior D, Sève B. Dietary tryptophan helps to preserve tryptophan homeostasis in pigs suffering from lung inflammation. J Anim Sci. 2008 ; 86: 3473-3479
37. De Jong RA, Nijman HW, Boezen HM, Volmer M, TenHoor KA, Krijnen J, et al. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer. Int J Gynecol Cancer. 2013 ; 21: 1320-1327
38. Changsirivathanathamrong D, Wang Y, Rajbhandari D, Maghzal GJ, Mak WM, Woolfe C, et al. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Crit Care Med. 2013 ; 39: 2678-2683
39. Ohashi H, Saito K, Fujii H, Wada H, Furuta N, Takemura M, et al. Changes in quinolinic acid production and its related enzymes following D-galactosamine and lipopolysaccharide-induced hepatic injury. Arch Biochem Biophys. 2004 ; 428: 154-159
40. Heseler K, Spekker K, Schmidt SK, MacKenzie CR, Däubener W. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. FEMS Immunol Med Microbiol. 2008 ; 52: 273-281
41. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, Musat-Marcu S, et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol. 2004 ; 173: 5909-5913
42. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immun Cell Biol. 2003 ; 81: 247-265